Medicare Enrolled

Dr. Brennen Cheek, M.D.

Radiology - Diagnostic · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3410 WORTH ST, Dallas, TX 75246
2143701400
In practice since 2006 (19 years)
NPI: 1124066139 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cheek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cheek? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cheek

Dr. Brennen Cheek is a radiology - diagnostic in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Cheek performed 31,581 Medicare services across 1,927 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cheek received a total of $349 from 8 pharmaceutical and/or device companies across 14 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cheek is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 1% volume in TX$ $349 industry payments

Medicare Practice Summary

Medicare Utilization ↗
31,581
Medicare services
Top 1% in TX for radiology - diagnostic
1,927
Unique beneficiaries
$187
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,662 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie18,600$194$545
Lutetium lu 177, dotatate, therapeutic, 1 millicurie6,100$244$684
Injection, granisetron hydrochloride, 100 mcg930$0$24
Dexamethasone injection (steroid)770$0$1
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session749$290$2,762
Calculation of radiation therapy dose721$53$365
CT guidance for radiation therapy592$97$613
Continuing radiation therapy consultation per week337$69$343
Radiation treatment management, 5 treatment sessions323$152$1,067
Design and construction of complex radiation treatment device243$99$710
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev180$181$700
Infusion into a vein for hydration, each additional hour156$10$75
Radioactive drug therapy through a vein133$64$439
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev125$188$700
Complex radiation therapy planning108$134$1,022
Design and construction of radiation treatment device for high precision radiation therapy99$372$2,640
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy99$60$637
New patient office visit, complex (60-74 min)87$164$709
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour84$16$100
Special radiation treatment82$110$1,794
Drug injection, under skin or into muscle79$11$96
Infusion, normal saline solution , 1000 cc79$2$19
Injection of drug or substance into vein76$29$247
High precision radiation therapy planning75$1,477$6,431
Cranial lesion surgery using radiation over multiple sessions71$811$8,210
New patient office visit (45-59 min)71$120$565
Blood draw (venipuncture)70$8$20
Complete blood count (CBC) with differential69$8$36
Special medical radiation therapy consultation56$111$402
Blood creatinine level56$5$31
Urea nitrogen level to assess kidney function, quantitative51$4$24
X-ray during radiation therapy44$11$126
Office visit, established patient, complex (40-54 min)43$136$496
Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved41$364$1,316
3d radiation therapy planning41$384$4,374
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area34$210$698
Injection of additional new drug or substance into vein28$12$108
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less27$51$313
Liver function blood test panel22$8$48
Management of cranial lesion surgery using radiation over multiple sessions16$508$3,609
Nuclear medicine study from skull base to mid-thigh with ct scan14$1,186$4,802
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
16.1% medium
82.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$349
Total received (2018-2024)
Avg $58/year across 6 years
Bottom 33% in TX for radiology - diagnostic
8
Companies
14
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$349 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$65
2023
$134
2022
$46
2020
$21
2019
$70
2018
$14

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$114
ABBVIE INC.
$65
Novartis Pharmaceuticals Corporation
$46
Novocure Inc.
$39
Advanced Accelerator Applications
$31
GT Medical Technologies, Inc
$21
Pharmacyclics LLC, An AbbVie Company
$20
Bayer HealthCare Pharmaceuticals Inc.
$14
Top 3 companies account for 64.6% of total payments
Associated products mentioned in payments ›
EPKINLY · GammaTile · IMBRUVICA · Lutathera · Oncology · Xofigo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1 per 100 Medicare services performed
Looking for a radiology - diagnostic in Dallas?
Compare radiology - diagnostics in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse radiology - diagnostics nearby

Geographic Context

Radiology - Diagnostics within 10 mi
58
Per 100K population
2.2
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cheek is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cheek experienced with lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie?
Based on Medicare claims data, Dr. Cheek performed 18,600 lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cheek receive payments from pharmaceutical companies?
Yes. Dr. Cheek received a total of $349 from 8 companies across 14 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cheek's costs compare to other radiology - diagnostics in Dallas?
Dr. Cheek's average Medicare payment per service is $187. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cheek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →